[go: up one dir, main page]

PT1003525E - Composicao e metodo para a regulacao da proliferacao e da morte celular - Google Patents

Composicao e metodo para a regulacao da proliferacao e da morte celular

Info

Publication number
PT1003525E
PT1003525E PT98938555T PT98938555T PT1003525E PT 1003525 E PT1003525 E PT 1003525E PT 98938555 T PT98938555 T PT 98938555T PT 98938555 T PT98938555 T PT 98938555T PT 1003525 E PT1003525 E PT 1003525E
Authority
PT
Portugal
Prior art keywords
composition
proliferation
regulation
cell death
dna
Prior art date
Application number
PT98938555T
Other languages
English (en)
Inventor
Nigel C Phillips
Mario C Fillion
Original Assignee
Bioniche Life Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioniche Life Sciences Inc filed Critical Bioniche Life Sciences Inc
Publication of PT1003525E publication Critical patent/PT1003525E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/711—Natural deoxyribonucleic acids, i.e. containing only 2'-deoxyriboses attached to adenine, guanine, cytosine or thymine and having 3'-5' phosphodiester links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/713—Double-stranded nucleic acids or oligonucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6901—Conjugates being cells, cell fragments, viruses, ghosts, red blood cells or viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
PT98938555T 1997-08-05 1998-08-05 Composicao e metodo para a regulacao da proliferacao e da morte celular PT1003525E (pt)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US5477797P 1997-08-05 1997-08-05
US7511198P 1998-02-18 1998-02-18
US7506798P 1998-02-18 1998-02-18
US8631798P 1998-05-21 1998-05-21

Publications (1)

Publication Number Publication Date
PT1003525E true PT1003525E (pt) 2003-03-31

Family

ID=27489673

Family Applications (1)

Application Number Title Priority Date Filing Date
PT98938555T PT1003525E (pt) 1997-08-05 1998-08-05 Composicao e metodo para a regulacao da proliferacao e da morte celular

Country Status (17)

Country Link
US (2) US6329347B1 (pt)
EP (1) EP1003525B1 (pt)
JP (2) JP4335435B2 (pt)
KR (1) KR100533576B1 (pt)
AT (1) ATE227996T1 (pt)
AU (1) AU736450B2 (pt)
BR (1) BR9815602A (pt)
CA (1) CA2299548C (pt)
DE (1) DE69809561T2 (pt)
DK (1) DK1003525T3 (pt)
ES (1) ES2187047T3 (pt)
HU (1) HU227921B1 (pt)
IL (3) IL134371A0 (pt)
NO (1) NO322450B1 (pt)
NZ (1) NZ502674A (pt)
PT (1) PT1003525E (pt)
WO (1) WO1999007383A1 (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6329347B1 (en) 1997-08-05 2001-12-11 Bioniche Life Sciences Inc. Composition and method for the treatment of bladder cancer
WO1999042113A1 (en) * 1998-02-18 1999-08-26 Bioniche Life Sciences Inc. Composition and method for the treatment of bladder cancer
NZ511941A (en) * 1998-12-04 2003-04-29 Bioniche Life Sciences Inc Use of Mycobacterium phlei DNA in chemotherapeutic compositions
DK1135164T3 (da) * 1998-12-04 2004-12-20 Bioniche Life Sciences Inc Sammensætning til behandling af inflammation
US6809081B1 (en) 1998-12-04 2004-10-26 Bioniche Life Sciences, Inc. Chemotherapeutic composition and method
JP2002541114A (ja) * 1999-04-01 2002-12-03 バイオニケ ライフ サイエンシーズ インコーポレイテッド 前立腺癌の細胞におけるアポプトーシス誘導のための組成物および方法
US6794368B1 (en) * 1999-04-01 2004-09-21 Bioniche Life Sciences Inc. Composition and method for inducing apoptosis in prostate cancer cells
AU7501700A (en) * 1999-09-29 2001-04-30 Bioniche Life Sciences Inc. Method to disrupt mitochondrial function
DE60036019T2 (de) * 1999-12-13 2008-05-29 Bioniche Life Sciences Inc., Belleville Synthetische oligonukleotide die therapeutisch nützlich sind
EP1250152B1 (en) * 1999-12-28 2013-05-15 Bioniche Urology IP Inc. Synergistic composition containing hyaluronic acid in the treatment of cancer
US20030044352A1 (en) * 2001-04-24 2003-03-06 Phillips Nigel C. Method for evaluating the efficacy of treatment with bacterial DNA and bacterial cell walls
US6673566B1 (en) 2002-01-10 2004-01-06 The United States Of America As Represented By The Secretary Of Agriculture Diagnosis of pathogen infections through analysis of nitrite production by antigen stimulated leukocytes
CN101511391B (zh) * 2006-07-25 2013-03-13 利普生技术有限公司 N末端聚唾液酸化
KR20140031168A (ko) 2010-10-13 2014-03-12 바이오니취 유롤로지 아이피 인코포레이티드 세균 리보핵산 세포벽 조성물 및 이들의 제조 및 사용 방법

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3172815A (en) 1962-04-24 1965-03-09 Warner Lambert Pharmaceutical Method for preparing reticulo-endo-thelial system stimulant and stimulant thereof
US4152423A (en) 1971-11-19 1979-05-01 Agence Nationale De Valorisation De La Recherche (Anvar) Immunological agents
FR2160326B1 (pt) 1971-11-19 1975-02-07 Anvar
CH602920A5 (pt) 1973-02-23 1978-08-15 Wellcome Found
US3976544A (en) 1973-06-19 1976-08-24 The Agence Nationale De Valorisation De Le Recherche Water-soluble immunological adjuvants, in particular for vaccines, obtained from mycobacteria and related microorganisms and process for their extraction
FR2374042A1 (fr) 1976-06-04 1978-07-13 Merieux Inst Nouveau medicament immunostimulant et son procede de preparation
JPS54140710A (en) 1978-03-10 1979-11-01 Mitsui Toatsu Chem Inc Anti-tumor substance and its preparation
DE3011461C2 (de) 1980-03-25 1986-10-30 Dr. Madaus & Co, 5000 Köln Verwendung von Propionibakterien
US4520019A (en) 1982-04-29 1985-05-28 Ribi Immunochem Research, Inc. Stable composition and preparation thereof
US4579941A (en) 1982-08-13 1986-04-01 Mitsuitoatsu Chemicals, Inc. Thermally-denatured deoxyribonucleic acid MD-011 and antitumor agent
US4663306A (en) 1983-09-23 1987-05-05 Ribi Immunochem Research, Inc. Pyridine-soluble extract-refined detoxified endotoxin composition and use
GB8404280D0 (en) 1984-02-17 1984-03-21 Stanford J L Biological preparations
US4744984A (en) 1985-10-08 1988-05-17 Vetrepharm Research, Inc. Antiviral immunotherapeutic agent and preparation thereof
US4877611A (en) 1986-04-15 1989-10-31 Ribi Immunochem Research Inc. Vaccine containing tumor antigens and adjuvants
CN1102855C (zh) 1993-01-29 2003-03-12 维特里制药有限公司 免疫治疗组合物
US6329347B1 (en) 1997-08-05 2001-12-11 Bioniche Life Sciences Inc. Composition and method for the treatment of bladder cancer

Also Published As

Publication number Publication date
DE69809561T2 (de) 2003-09-25
JP4335435B2 (ja) 2009-09-30
WO1999007383A1 (en) 1999-02-18
EP1003525A1 (en) 2000-05-31
HU227921B1 (hu) 2012-06-28
CA2299548C (en) 2009-12-29
NO322450B1 (no) 2006-10-09
AU736450B2 (en) 2001-07-26
IL180924A0 (en) 2007-07-04
JP2001513504A (ja) 2001-09-04
DE69809561D1 (de) 2003-01-02
DK1003525T3 (da) 2003-03-24
BR9815602A (pt) 2001-12-11
ATE227996T1 (de) 2002-12-15
AU8723698A (en) 1999-03-01
IL134371A0 (en) 2001-04-30
HUP0003012A2 (hu) 2000-12-28
KR20010022643A (ko) 2001-03-26
IL134371A (en) 2007-07-24
IL180924A (en) 2010-11-30
CA2299548A1 (en) 1999-02-18
NO20000576D0 (no) 2000-02-04
KR100533576B1 (ko) 2005-12-05
WO1999007383B1 (en) 1999-03-25
NO20000576L (no) 2000-04-04
JP2008208140A (ja) 2008-09-11
EP1003525B1 (en) 2002-11-20
ES2187047T3 (es) 2003-05-16
NZ502674A (en) 2002-06-28
US6329347B1 (en) 2001-12-11
HUP0003012A3 (en) 2004-03-29
US6326357B1 (en) 2001-12-04

Similar Documents

Publication Publication Date Title
IL180924A (en) Method for regulating cell proliferation and cell death
AU3649397A (en) Precise efficacy assay methods for active agents including chemotherapeutic agents
AU1926899A (en) Exploiting genomics in the search for new drugs
DK274688D0 (da) Aktivering ex vivo af effektor-celler til maalrettet celledrab
DE60031997D1 (de) Umkehrtransfektionsverfahren
DK0880188T3 (da) CO-tolerant anodekatalysator til PEM-brændselsceller og fremgangsmåde til fremstilling deraf
ES2142363T3 (es) Materiales y metodos para la hipersecrecion de aminoacidos.
DK1681355T3 (da) Sekvensspecifik DNA-rekombination i eukaryote celler
EE03955B1 (et) Nukleiinhappe kasutamine ravimi valmistamiseks imetaja reproduktiivtrakti vähemalt mõne raku transfekteerimiseks
HUP0001937A2 (hu) Új vegyületek, eljárás előállításukra és alkalmazásuk nukleinsavak sejtekbe való bevitelére
ATE268904T1 (de) Zellbasiertes festphasentest
DE69012601D1 (de) Gentherapie durch stützgewebebezügliche Zellen.
DE3875396D1 (de) Mikrotraegermaterial fuer die zellkultur.
GB9825096D0 (en) Cells,culture methods and their uses
ATE226087T1 (de) Verwendung von neuen zelltod inducierenden mitteln im synergismus mit interferon
DK323088A (da) Koeleanlaeg til braendeselsceller
HUP0102413A1 (hu) Vektorok nukleinsavak bevitelére, ezeket tartalmazó készítmények és alkalmazásuk
ES2132027A1 (es) Desarrollo de una piel artificial mediante cultivo de queratinocitos sobre una base de fibrina y fibroblastos humanos y metodo de preparacion de esta piel para trasplante.
NL190728C (nl) Elektrodestructuur voor elektrochemische cellen.
ES2180586T3 (es) Procedimiento para la determinacion de un analito.
ATE273027T1 (de) Zusammensetzung zur behandlung von entzündungen
SI1196182T1 (sl) Postopek za povečanje zmogljivosti proizvodnje pri živali
JPS52156991A (en) Method for increasing activity of immobilized enzymes
FR2706483B1 (fr) Bioréacteur, destiné notamment à la culture de cellules.
BR0006197A (pt) Creme reativador de células capilares